Fredrik Widman - 15 Feb 2022 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Signature
By: Donna Spinola, Attorney-in-fact For: Fredrik Widman
Issuer symbol
ISRG
Transactions as of
15 Feb 2022
Net transactions value
-$94,894
Form type
4
Filing time
17 Feb 2022, 13:43:33 UTC
Previous filing
10 Jan 2022
Next filing
01 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $0 +486 +41% $0.000000 1,666 15 Feb 2022 Direct F1
transaction ISRG Common Stock Tax liability $55,548 -192 -12% $289.31 1,474 15 Feb 2022 Direct F1
transaction ISRG Common Stock Options Exercise $0 +393 +27% $0.000000 1,867 15 Feb 2022 Direct F1
transaction ISRG Common Stock Tax liability $39,346 -136 -7.3% $289.31 1,731 15 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Restricted Stock Units Options Exercise $0 -486 -100% $0.000000* 0 15 Feb 2022 Common Stock 486 $0.000000 Direct F2
transaction ISRG Restricted Stock Units Options Exercise $0 -393 -50% $0.000000 393 15 Feb 2022 Common Stock 393 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
F2 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.